ATM/ATR

ATM and ATR inhibitors act on ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) kinases. The ATM gene was cloned in 1995 and encodes a protein similar to phosphatidylinositol 3-kinase (PI3K). ATR was cloned in 1996 as a candidate human cell cycle checkpoint protein. ATM responds mainly to DNA double-strand breaks, whereas ATR is activated by stalled replication forks. KU-55933, described in 2004 as a specific ATM inhibitor, is joined by KU-60019 and AZD0156. Ceralasertib, VE-821 and BAY-1895344 inhibit ATR and are used to study replication stress. Broader inhibitors of PI3K-related kinases, such as wortmannin, also appear in this list. Inhibitors of DNA-dependent protein kinase are listed in the sibling category DNA-PK.

Items 76-83 of 83

  • ATR-IN-5
    Cat. No.
    A54118

    ATR-IN-5

    ATR-IN-5 is a potent inhibitor of ATR (Ataxia Telangiectasia and Rad3-related protein), a member of the PI3K-related kinase family that plays a crucial role in maintaining genome stability and facilitating DNA damage repair. This compound is valuable for research into ATR kinase-mediated diseases, including various proliferative disorders and cancers. Its inhibitory effects on ATR provide a useful tool for investigating therapeutic strategies targeting DNA repair mechanisms in these conditions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • ATM Inhibitor-9
    Cat. No.
    A54119

    ATM Inhibitor-9

    ATM Inhibitor-9 is a selective inhibitor targeting ATM kinase, with an IC50 value of 5 nM. It effectively impairs ATM-mediated signaling pathways, making it an invaluable tool for cancer research, particularly in studies involving DNA damage response and repair mechanisms. This compound can be used to explore the role of ATM in tumor biology and therapeutic resistance.

    Out of stock

    All 3 sizes
  • ATM Inhibitor-8
    Cat. No.
    A54120

    ATM Inhibitor-8

    ATM Inhibitor-8 is a selective and potent inhibitor of Ataxia Telangiectasia Mutated (ATM) kinase, exhibiting an IC50 of 1.15 nM. This compound demonstrates significant anti-tumor activity, making it valuable for research in cancer biology and therapeutic development. Its oral bioavailability enhances its utility in in vivo studies exploring the role of ATM inhibition in various malignancies.

    Out of stock

    All 3 sizes
  • ATR kinase-IN-3
    Cat. No.
    A54121

    ATR kinase-IN-3

    ATR kinase-IN-3 is a potent ATR protein kinase inhibitor with a Ki value ranging from 0.01 to 1 μM. This compound significantly modulates the ATR signaling pathway, making it valuable for studies in cancer biology, particularly in understanding DNA damage response mechanisms. Its ability to inhibit ATR activity can aid in assessing the therapeutic potential of targeting this pathway in various cancer models.

    Out of stock

    All 3 sizes
  • ATR-IN-16
    Cat. No.
    A54122

    ATR-IN-16

    ATR-IN-16 is a potent inhibitor of the ATR kinase, a critical regulator of the DNA damage response pathway. This compound demonstrates significant anticancer activity, exhibiting an IC50 of 410 nM in LoVo cells. ATR-IN-16 is applicable in cancer research, particularly for studies focused on DNA repair mechanisms and therapeutic strategies targeting ATR signaling.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • ATR-IN-33
    Cat. No.
    A54123

    ATR-IN-33

    ATR-IN-33 is a selective ATR kinase inhibitor that targets the ataxia telangiectasia and Rad3-related protein, involved in the DNA damage response. By inhibiting ATR activity, ATR-IN-33 effectively impairs cellular repair mechanisms, which can lead to enhanced sensitivity to DNA-damaging agents. This compound is valuable for research applications in cancer biology, particularly in studies assessing tumor response to therapy and exploring mechanisms of resistance.

    Out of stock

    All 3 sizes
  • Ceralasertib formate
    Cat. No.
    A54124

    Ceralasertib formate

    Synonyms: AZD-6738 formate

    Ceralasertib formate is a highly potent and selective inhibitor of ATR (ataxia telangiectasia and Rad3-related protein) with an IC50 value of 1 nM. This compound effectively inhibits cell viability, induces DNA damage, and promotes cellular senescence. Ceralasertib formate demonstrates notable antitumor activity and is valuable for research applications focused on cancer therapeutics and DNA damage response pathways.

    25 mg
    $1,275.00
    All 1 sizes
  • (R,R)-ART0380
    Cat. No.
    B10855

    (R,R)-ART0380

    (R,R)-ART0380 is the enantiomer of ART0380 and functions as a potent and selective inhibitor of ATR (Ataxia Telangiectasia and Rad3 related protein). This compound exhibits significant anti-tumor activity and is ideal for research applications focused on advanced or metastatic solid tumors. Its selective inhibition makes it a valuable tool for exploring novel therapeutic strategies in cancer research.

    1 mg
    $50.00
    5 mg
    $130.00
    All 6 sizes

Items 76-83 of 83

Added to your cart

View Cart Checkout

    Loading...